3rd annual report 2009-2010ongc teri biotech limited notice notice is hereby given that the 3rd...
TRANSCRIPT
3rd ANNUAL REPORT
2009-2010
ONGC TERI Biotech Limited
ONGC Teri Biotech Limited
BOARD OF DIRECTORS
Shri A.K.Hazarika Chairman
Dr. Banwari Lal Director & CEO
Shri M.M.Joshi Director
Dr. D.M.Kale Director
Dr. R. V. Marathe Director
Shri V.K. Jain Director
STATUTORY AUDITORS
M/s A. K. Khurana & Associates
Chartered Accountants,
New Delhi
BANKERS
State Bank of Hyderabad,
Lodhi Road, New Delhi
REGISTERED OFFICE
The Energy and Resources Institute,
Darbari Seth Block, IHC Complex,
Lodhi Road, New Delhi-110003
ONGC Teri Biotech Limited
NOTICE
NOTICE is hereby given that the 3rd Annual General Meeting of the Members of
ONGC TERI Biotech Limited will be held on Thursday, the 24th June, 2010 at 17.00
Hrs. at Conference Room, 7th Floor, ONGC, Jeevan Bharti, New Delhi-110001, to
transact the following Business;
As Ordinary Business:
1. To receive, consider and adopt the Audited Balance Sheet as at 31st March,
2010 and the Profit and Loss Account of the Company for the financial year
ended on that date together with the Reports of the Directors and the
Auditors thereon.
2. To appoint a Director in place of Shri A.K.Hazarika who retires by rotation
and being eligible, offers himself for re-appointment.
3. To appoint a Director in place of Shri M.M.Joshi who retires by rotation and
being eligible, offers himself for reappointment.
As Special Business:
4. To consider and if thought fit, to pass with or without modification(s), the
following as a Special Resolution:
“RESOLVED THAT pursuant to section 224A of the Companies Act, 1956,
(including any statutory modification or re-enactment thereof for the time
being in force and as may be enacted from time to time) M/s A. K.
Khurana & Associates, Chartered Accountants, Membership No.084245,
the retiring Statutory Auditors of the Company from whom the Company
has received a Certificate under Section 224 (1)(B) of the Act, being
eligible, be and are hereby, re-appointed as the Statutory Auditors of the
Company to hold office from the conclusion of this meeting until the
conclusion of the next Annual General Meeting of the Company at a
remuneration of Rs.50,000/- exclusive of the applicable Service Tax and out
of pocket expenses.”
By Order of the Board of Directors
for ONGC TERI Biotech Limited
Sd/-
Place: New Delhi (S.K.C.Mathur)
Dated: 24th June, 2010 Authorized Signatory NOTES:
1. A Member entitled to attend and vote at the meeting is entitled to appoint a Proxy to
attend and vote instead of himself and the Proxy need not be a Member of the
Company. Proxies in order to be effective must be received by the Company not less
than forty-eight hours before the meeting.
2. The relevant Explanatory Statement pursuant to Section 173(2) of the Companies Act,
1956 in respect of item nos. 4 to 6 stated above is annexed hereto.
ONGC Teri Biotech Limited
EXPLANATORY STATEMENT PURSUANT TO SECTION 173(2) OF THE COMPANIES ACT,
1956
Item No. 4
As per section 224A of the Companies Act, 1956, the re-appointment of an auditor
shall be made by a Special Resolution since Oil and Natural Gas Corporation
Limited, a Government Company holds more than 25% (Twenty-five) of the
Subscribed Capital of the Company.
The Board of Directors recommends the resolution for your approval as a Special
Resolution.
None of the Directors of the Company is in any way concerned or interested in the
resolution.
By Order of the Board of Directors
for ONGC TERI Biotech Limited
Place: New Delhi (S.K.C.Mathur)
Dated: 24th June, 2010 Authorized Signatory
ONGC Teri Biotech Limited
DIRECTORS’REPORT Dear Members,
Your Directors are pleased to present the 3rd Annual Report together with the
Audited Accounts of the Company for the period ending on 31st March, 2010.
Financial Results
The Company has followed the Project Completion method for recognizing
revenue. Based on Projects closed, your Company during the year has generated
gross revenue of Rs. 738.58 lakhs (Previous year - Rs. 80.75 lakhs). After meeting the
operational & other expenses, after tax carried forward net profit of your Company
is Rs.163.13 lakhs (Previous year - Rs.5.42 lakhs).
Dividend
Your Directors do not recommend payment of any dividend for the period ended
31st March, 2010.
Operations Highlights
Your Company which was set-up as a Joint-Venture of Oil and Natural Gas
Corporation Ltd., (ONGC) and The Energy and Resources Institute (TERI) continues
to provide oil field services to the Oil and Gas Industry using microbial methods
primarily in four areas, namely:
1. Bio-remediation using Oilzapper Technology;
2. Microbial Enhanced Oil Recovery;
3. Application of Paraffin Deposition Bacteria (PDB) technology to prevent
chocking of Production Tubing; and
4. Wax Deposition Prevention (WDP) in flow lines.
Order Book
(i) Bioremediation Jobs
Your Company during the year successfully executed the Bio-remediation
job by use of Oilzapper Technology in Thol Village, Mehsana Asset, ONGC,
by excavating 14693.50 m3 of oily sludge from contaminated project land
caused due to leakage in CTF Trunk line and re-filling the same with good
soil.
Application of Oilzapper at the bioremediation site Lying of HPPE liner at the bioremediation site
ONGC Teri Biotech Limited
The following work orders, which are under execution by your Company,
were also received during the year:
i) 27,614.65 MT of oil contaminated soil/oily sludge at different field
locations of Ahmedabad Asset, ONGC;
ii) 12900 MT of oily sludge /oil contaminated soil in pits at Santhal-1,
Mehsana Asset , ONGC;
iii) 8046 m3 of oily sludge in oil fields of Oil India Ltd, Duliajan;
iv) 150 tonnes of waste oily sludge / oil contaminated soil at
Kesanapalli (W) GGS, Rajahmundry Asset, ONGC:
v) 500 tonnes of oily sludge at Uran, ONGC; and
vi) 10,679 tonnes of waste oily sludge/oil contaminated soil &
Transportation of 1,597 M3 of oil contaminated soil from site at
Mehsana Asset, ONGC; and
vii) 250 tonnes oily sludge at Numligarh Refinery, Numligarh, etc.
Before After
Bioremediation site at Kathalguri OCS outside Pit Bioremediation site at Kathalguri OCS outside Pit
(ii) Microbial Enhanced Oil Recovery (MEoR)
Out of a work order for execution of 50 Microbial Enhanced Oil Recovery
(MEoR) job from Ahmedabad Asset, ONGC, your Company during the
year could complete job on 27 wells only due to some delays in handing
over of wells.
Execution of MEOR job in oil wells
Mehsana PDB Job
5
42
51
21
56
31
71
40
77
86 8792
63
98
67 68 71 74
113120
126132
147152
177182
210
226
131
4135
2821
14
0
30
60
90
120
150
180
210
240
SB
N#83
JT
N#164
SB
N#251
SO
B #
219
SB
N#55
SB
N #
208
JT
N #
91
SO
B C
TF
# 2
53
JT
N #
94
SO
B C
TF
# 2
53
SO
B #
113
SO
B #
198
JT
N #
99
SO
B #
159
JT
N #
106
JT
N #
118
So
b #
208
Nk c
tf #
437
JT
N #
119
SO
B #
132
JT
N #
61
SO
B C
TF
# 1
72
SO
B #
228
SO
B #
225
SO
B #
63
JT
N #
116
SO
B #
142
NK
# 4
02
JT
N #
179
SO
B #
207
SO
B #
215
JT
N#120
SB
N#148
JT
N#78
JT
N#162
LN
C #
43
Well no
No
of
Sc
rap
ing
fre
e d
ay
s
ONGC Teri Biotech Limited
(iii) Wax Deposition Prevention (WDP)/ Paraffin Degrading Bacterial (PDB)
During the year, your Company successfully completed Paraffin
Degrading Bacterial (PDB) jobs in 50 wells of Mehsana Asset, ONGC, while
Wax Deposition Prevention (WDP) jobs in about 80 kms. of flow lines of
Ahmedabad Asset, ONGC is nearing completion.
Execution of PDB job in oil wells
Future Outlook
The future outlook of your Company is full of promise as its order book is overflowing
with several proposals in pipeline and nearing maturity.
Your Company has a running agreement with ONGC to provide bio-remedial
solutions and services to all its Assets and producing fields spread throughout India
for enhanced crude oil production. An MOU has also been signed with Oil India
Ltd. for an initial period of 10 years. First order has already been received for
bioremediation of 8046 cubic metric of oily sludge in their oil spilled fields by using
Oilzapper Technology, while another Work order on Prevention of Paraffin
Deposition in Oil well tubing is expected to be received soon.
An order for a bio-remediation job of 4,800 MT at Belur Scrap Yard under Eastern
Railway, West Bengal, is expected to be received soon as the proposal submitted
by your Company has been accepted. Orders for bioremediation job are also
expected to be received from Reliance Industry and Tata Power.
On the International front, the pre-qualification exercise for remediation of existing
pits and contaminated soil fields of Kuwait Oil Company (KoC) is progressing. Your
Company participated in the Oil Lake/ Oil Contaminated Soil Remediation and
Ecological Restoration Forum organized by Kuwait National Focal Point in
collaboration with KoC for pre-qualified bidders. Through M/s Jindal Petroleum
Limited, Gurgaon, your Company has received an order to perform MEoR job on
two wells in Georgia on pilot basis.
ONGC Teri Biotech Limited
Fixed Deposit
The Company has not accepted any Fixed Deposits from the public.
Auditors
M/s A.N. Khurana & Associates, Chartered Accountants, New Delhi, Statutory
Auditors of the Company holds office until the conclusion of the forthcoming
Annual General Meeting of the Company and are recommended for
reappointment. The Company has received certificate from them to the effect
that their appointment, if made, would be within the provisions of Section 224(1) of
the Companies Act, 1956. There is no qualification in the Auditors’ Report for the
year ended 31st March, 2010.
Particulars of Employees
There is no employee in the Company whose particulars are required to be given
under Section217 (2A) of the Companies Act, 1956.
Particulars of Conservation of Energy, Technology Absorption etc.
Your Company while providing bioremediation solutions to the Oil and Gas Industry
is continuously endeavouring to develop most energy efficient processes and
devices. Wherever possible, energy conservation measures have been
implemented. For example, use of low pressure pumps to send environmental
friendly microbial solution for recovery of trapped oil in the reservoirs; use of
microbial system to form bio-films in the pipelines preventing paraffin deposition
for considerable time and eliminating use of energy sapping drilling instruments,
shut-down of operations and use of energy intensive mechanical scrappers;
microbes using toxic waste as source of nutrients and converting the same to
compost, requiring no external energy and the wastes converted to CO2, water
and bacterial biomass, etc. Microbial methods used are thus latest in the fast
evolving field of bioremediation solutions backed by robust research and
development. Effort to conserve & optimize use of energy and absorb new
techniques is a continuous process in your Company. The Company has not
earned but has spent Rs.47, 180 (Previous Year: Nil) in foreign exchange during the
accounting period ended 31st March, 2010.
Directors’ Responsibility Statement
As required under Section 217 (2AA) of the Companies Act, 1956, your Directors
state that:
(i) that in the preparation of the Annual Accounts, the applicable
accounting standards have been followed;
(ii) that the accounting policies selected and applied are consistent and
the judgment and estimates made are reasonable and prudent so as
to give a true and fair view of the state of affairs of the Company at
the end of the financial year and of the profit or loss of the Company
for that period;
ONGC Teri Biotech Limited
(iii) that proper and sufficient care has been taken for the maintenance of
adequate accounting records in accordance with the provisions of
the Companies Act,1956 for safeguarding the assets of the Company
and for preventing and detecting fraud and other irregularities;
(iv) that the Annual Accounts have been prepared on a going concern
basis.
Directors
In accordance with the provisions of the Companies Act, 1956 and the Articles of
Association of the Company, S/Shri A.K.Hazarika and M.M.Joshi, Directors, retire by
rotation and being eligible, offer themselves for re-appointment.
None of the Directors are disqualified from being appointed as Directors in terms of
provisions of Section 274 (1) (g) of the Companies Act, 1956.
Acknowledgements
The Directors wish to thank and deeply acknowledge the co-operation, assistance
and support extended by ONGC, TERI and other shareholders, Company’s bankers
and Statutory Auditors etc. The Directors also wish to place on record their
appreciation for the all-round co-operation and contribution made at all levels in
the formative years of the Company.
Regd. Office: On behalf of the Board of Directors
for ONGC TERI Biotech Limited
The Energy and Resources Institute,
Darbari Seth Block, IHC Complex,
Lodhi Road, New Delhi-110003
(A.K.Hazarika)
Date: 24th June, 2010 Chairman
ONGC Teri Biotech Limited
AUDITOR’S REPORT
The Shareholders of ONGC TERI BIOTECH LIMITED
We have audited the attached Balance Sheet of ONGC TERI BIOTECH
LIMITED as at 31st March, 2010 and also the Profit and Loss Account for the
year ended on that date annexed thereto. These financial statements are
the responsibility of the Company’s management. Our responsibility is to
express an opinion on these financial statements based on our audit.
We conducted our audit in accordance with auditing standards generally
accepted in India. Those standards require that we plan and perform the
audit to obtain reasonable assurance about whether the financial
statements are free of material misstatement. An audit includes examining,
on a test basis, evidence supporting the amounts and the disclosures in the
financial statements. An audit also includes assessing the accounting
principles used and significant estimates made by management, as well as
evaluating the overall financial statement presentation. We believe that our
audit provides a reasonable basis for our opinion.
As required by the Companies (Auditor’s Report) order 2003 issued by the
Central Government of India in terms of Section (4A) of Section 227 of the
Companies Act 1956, we enclose in the annexure a statement on the
matters specified in paragraphs 4 & 5 of the said order.
Further to our comments in the Annexure referred to above, we report that:
i) We have obtained all the information and explanations which to the
best of our knowledge and belief were necessary for the purpose of
our audit.
ii) In our opinion, proper Books of Account as required by law have
been kept by the Company so far as it appears from our examination
of such books;
iii) The Balance Sheet and Profit and Loss Account dealt with by this
report are in agreement with the Books of Account;
ONGC Teri Biotech Limited
iv) In our opinion, the Balance Sheet and Profit and Loss Account dealt
with by this report comply with the Accounting Standards referred to
in sub-section (3C) of Section 211 of the Companies Act, 1956.
v) On the basis of written representations received from the Directors, as
on 31st March 2010, and taken on record by the Board of Directors,
we report that none of the Directors is disqualified as on 31st March
2010 from being appointed as a director in terms of clause (g) of sub-
section (1) of section 274 of the Companies Act, 1956.
vi) In our opinion and to the best of our information and according to the
explanations given to us, the said accounts give the information
required by the Companies Act, 1956, in the manner so required and
give a true and fair view in conformity with the accounting principles
generally accepted in India:
(a) In the case of the Balance Sheet, of the State of Affairs of the
Company as at 31st March, 2010
(b) In the case of the Profit and Loss Account, of the Profit for the year
ended on that date.
For A.K.KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
Sd/-
Place: New Delhi (ASHOK KHURANA)
Dated: 22nd May, 2010 SOLE PRACTITIONER
Membership No.: 084245
ONGC Teri Biotech Limited
ANNEXURE TO AUDITOR’S REPORT
1. a) The Company has maintained proper records showing full particulars
including quantitative details and situation of fixed assets.
b) The Company has a programme of physical verification of fixed assets
which is, in our opinion, reasonable having regard to the size of the
Company and the nature of its assets. In accordance with this programme,
certain fixed assets have been physically verified by the management
during the year and no serious discrepancies have been noticed on such
verification.
c) The Company has not disposed off any fixed assets during the year.
2. The nature of business of the Company does not require it to maintain
inventories except for the limited purpose of consumption of chemicals and
consumables at the site locations of customers while executing jobs.
a) As per the information and explanation given to us, the same have been
physically verified by the management at regular intervals.
b) In our opinion and according to the information and examinations given to
us, the procedures of physical verification followed by the management are
reasonable and adequate in relation to the size and nature of its business.
c) On the basis of our examination of the records, we are of the opinion that
the Company is maintaining reasonable proper records in view of the nature
and size of its operations.
3. The Company has not granted or taken any loans, secured or unsecured
to/from companies, firm or other parties covered in the register maintained
under Section 301 of the Companies Act, 1956.
4. In our opinion and according to the information and explanations given to
us, having regard to the explanations that some of the items purchased and
services availed/ rendered are of special nature and suitable alternative
sources do not exist for obtaining comparable quotations, there are
adequate internal control procedures commensurate with the size of the
Company and the nature of business with regard to purchase of inventory
and fixed assets and with regard to the services rendered. During the course
of our audit, we have not observed any continuing major weaknesses in
such internal control.
5. The Company has not accepted any deposits from the public under the
meaning of section 58A and 58AA of the Companies Act, 1956 or any other
relevant provision of the Act and the rules framed there under.
6. In our opinion and according to the information and explanations given to
us, the Company is generally regular in depositing undisputed statutory dues
including income tax, sales tax, service tax, custom duty and cess and other
statutory dues, if any with the appropriate authorities. There are no arrears of
outstanding statutory dues as at 31st March 2010 for a period of more than
six months from the date they became payable.
ONGC Teri Biotech Limited
7. The Company has neither accumulated losses nor has incurred cash losses in
the financial year or in the immediately preceding financial year.
8. The Company has not granted loans and advances on the basis of security
by way of pledge of shares and other securities.
9. Based upon the audit procedures performed and as per the information
and explanations given to us by the management, we report that no fraud
on or by the Company has been noticed during the year.
10. The Comment on other matters are required by the Company’s (Auditor’s
Report) Order, 2003 are not given as the same are not applicable to the
Company.
For A.K.KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
Sd/-
Place: New Delhi (ASHOK KHURANA)
Dated: 22nd May, 2010 SOLE PRACTITIONER
Membership No.: 084245
ONGC Teri Biotech Limited
BALANCE SHEET AS AT 31ST MARCH, 2010
PARTICULARS SCHEDULE CURRENT YEAR PREVIOUS YEAR
SOURCE OF FUNDS
SHARE CAPITAL 'A' 500000.00 500000.00
RESERVES & SURPLUS
Opening balance 542499.20
Add: Net Profit 16313058.44 16855557.64 542499.20
17355557.64 1042499.20
APPLICATION OF FUNDS
FIXED ASSETS 'B' 231092.09 -
WORKING CAPITAL 'C' 16929142.35 817965.60
MISCELLANEOUS EXPENDITURE
(To the extent not written
off / adjusted)
- Preliminary / Pre-Operative Expenses
Opening Balance 224533.60
Less: written off during the year 56133.40 168400.20 224533.60
DEFERRED TAX ASSET 26923.00 -
17355557.64 1042499.20
Notes to Accounts are given in Schedule ' E'
Auditor's Report As per our separate report of even date attached
for A .K .KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
Sd/- Sd/- Sd/- (ASHOK KHURANA) ( A.K.HAZARIKA) (DR. BANWARI LAL)
SOLE PRACTITIONER CHAIRMAN DIRECTOR &CEO
Membership No.:084245
PLACE : NEW DELHI
DATED : 22nd
May, 2010
ONGC Teri Biotech Limited
PROFIT & LOSS ACCOUNT FOR THE YEAR ENDED 31ST MARCH 2010
PARTICULARS SCHEDULE CURRENT PREVIOUS
YEAR YEAR
INCOME
REVENUE FROM PROJECTS CLOSED 73,858,500.00 8075885.00
INTEREST ON FIXED DEPOSIT 2,678,227.00 -
TOTAL OF 'A' 76,536,727.00 8075885.00
EXPENDITURE
COSTS ON PROJECTS CLOSED 46384722.00 7097786.00
PERSONNEL, ADMINISTRATIVE,
SELLING & FINANCIAL EXPENSES 'D' 5,464,924.65 193003.80
DEPRECIATION 'B' 55,641.91 -
TOTAL OF 'B' 51,905,288.56 7290789.80
PROFIT / (LOSS) BEFORE TAX ('A') - ('B') 24,631,438.44 785095.20
ADD: DEFERRED TAX ASSET 26,923.00
24,658,361.44
LESS: PROVISION FOR INCOME TAX 8,345,303.00 242596.00
PROFIT / (LOSS) AFTER TAX 16,313,058.44 542499.20
Notes to Accounts are given in Schedule ' E '
Auditor's Report
As per our separate report of even date attached
for A .K .KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
Sd/- Sd/- Sd/-
(ASHOK KHURANA) (A.K.HAZARIKA) (DR. BANWARI LAL)
SOLE PRACTITIONER CHAIRMAN DIRECTOR & CEO
MEMBERSHIP NO.:084245
PLACE : NEW DELHI
DATED : 22nd May, 2010
ONGC Teri Biotech Limited
PARTICULARS CURRENT YEAR PREVIOUS YEAR
AUTHORISED SHARE CAPITAL
10,00,000 Equity Shares of Rs.10/-each 10000000.00 100000000.00
ISSUED, SUBSCRIBED AND PAID UP
50,000 Equity Shares of Rs.10/-each fully paid up 500000.00 500000.00
500000.00 500000.00
SCHEDULE 'A'
SCHEDULE OF SHARE CAPITAL FORMING PART OF BALANCE SHEET
AS AT 31ST MARCH, 2010
ONGC Teri Biotech Limited
SCHEDULE ‘B’
SCHEDULE OF FIXED ASSETS FORMING PART OF ACCOUNTS FOR THE YEAR
ENDED 31ST MARCH, 2010
PARTICULARS
GROSS BLOCK DEPRECIATION NET BLOCK
AS ON 31.03.2009
ADDITION SALES AS ON 31.03.10
UP TO 31.03.09
FOR THE YEAR
UP TO 31.03.10
AS ON 31.03.2009
AS ON 31.03.10
COMPUTER - 231900.00 - 231900.00 - 53693.44 53693.44 - 178206.56
FURNITURE - 12098.00 - 12098.00 - 635.92 635.92 - 11462.08
OFFICE EQUIPMENT - 13600.00 - 13600.00 - 435.36 435.36 - 13164.64
SCIENTIFIC EQUIPMENT - 29136.00 - 29136.00 - 877.19 877.19 - 28258.81
TOTAL Previous Year’s Figures
- 286734.00 - 286734.00 - 55641.91 55641.91 - 231092.09
-
-
-
-
-
-
-
-
-
ONGC Teri Biotech Limited
SCHEDULE 'C'
SCHEDULE OF WORKING CAPITAL FORMING PART OF BALANCE SHEET
AS AT 31ST MARCH, 2010
PARTICULARS CURRENT YEAR PREVIOUS YEAR
CURRENT ASSETS, LOANS & ADVANCES
COSTS ON ONGOING PROJECTS 51502204.00 12301019.00
SUNDRY DEBTORS
(Unsecured considered good)
- Outstanding for period exceeding six months 1697253.00 - Others 9922588.00 11619841.00 -
CASH & BANK BALANCES
- Balance with Scheduled Bank 3578039.35 10080687.60
Advances recoverable in cash or in
kind or for value to be received/
adjusted (Unsecured considered good)
- Prepaid Expenses - 13296.00
- Tax Deducted at Source (against ongoing projects) 2759604.00 539692.00
- Tax Deducted at Source (against closed projects) 1869287.00 183920.00
- TDS on Fixed Deposit 268465.00 -
- Security Deposit 3502750.00 -
- Advance Income Tax 5860050.00 61800.00
- Service Tax (Cenvat Credit) - 74334.00
- Service Tax Refundable - 92001.00
- Fixed Deposit 76910000.00 -
- Interest accrued on Fixed Deposit 2367054.00 -
- Advance to suppliers 10364.00 -
- Advance to Staff 21200.00 2000.00
TOTAL OF 'A' 160268858.35 23348749.60
CURRENT LIABILITIES & PROVISIONS
SUNDRY CREDITORS
- For trade 2926842.00 1617038.00
- For Expenses 1327270.00 55150.00
4254112.00 1672188.00
INCOME FROM ONGOING PROJECTS 128,739,294.00 20616000.00
PROVISION FOR TAXATION 8587899.00 242596.00
PROVISION FOR SERVICE TAX 993752.00
TDS PAYABLE 764659.00
TOTAL OF 'B' 143339716.00 22530784.00
WORKING CAPITAL 'A' - 'B' 16929142.35 817965.60
ONGC Teri Biotech Limited
SCHEDULE 'D'
SCHEDULE OF PERSONNEL, ADMINISTRATIVE SELLING AND FINANCIAL EXPENSES
FORMING PART OF PROFIT AND LOSS ACCOUNT FOR THE YEAR ENDED 31ST MARCH, 2010
PARTICULARS CURRENT YEAR PREVIOUS YEAR
Staff salary, allowances and reimbursement 2499651.00 -
Staff Welfare 2309.00 -
Website Development & Maintenance charges 13296.00 54681.00
Office Rent 96000.00 -
Books & Periodicals 1935.00 5000.00
Telephone Expenses 68164.00 -
Courier charges 23510.00 -
Electricity charges 41350.00 -
Professional / Consultancy Fees 207947.00 7664.40 Travelling & Conveyance (including foreign travel Rs. 1,58,811) 1199646.00 -
(Includes incurred on director Rs.2,36,885, previous year Nil)
Miscellaneous / Sundry Expenses 102997.00 44.00
Printing & Stationery 89542.25 4826.00
Repair & Maintenance-Others 32335.00 -
Taxes & Fees 772054.00 -
Advertisement, Publicity & Business Promotion 122493.00 -
Payment to Auditors
- Statutory Audit 50000.00
-Tax Audit 10000.00
- Income Tax Matters 24000.00
-Service Tax Matters 20000.00
- Other Services 2100.00
-Out of pocket Expenses 5000.00
-Service Tax 11444.00 122544.00 64230.00
Bank charges 13018.00 425.00
Preliminary / Preoperative Expenses w/off 56133.40 56133.40
5464924.65 193003.80
ONGC Teri Biotech Limited
SCHEDULE - E
NOTES TO ACCOUNTS FORMING PART OF ACCOUNTS FOR THE YEAR
ENDED 31ST MARCH, 2010
1. SIGNIFICANT ACCOUNTING POLICIES
The Company has followed mercantile system of accounting and
recognises Income & Expenditure on accrual basis. The accounts are prepared on historical cost basis, as a going concern, and are
consistent with the generally accepted accounting principles.
2. FIXED ASSETS/ DEPRECIATION
Fixed Assets are stated at cost. Depreciation on Fixed assets has been provided on written down value basis according to the rates
prescribed in Schedule XIV of the Companies Act, 1956 for the actual period of use.
3. REVENUE RECOGNITION
Revenue from projects based on execution and costs attributable and allocable thereto are recognized on full completion or
substantial completion of the related projects and is billed in accordance with the contractual terms specified in the contracts/
agreement.
4. JOINT VENTURE/ ASSOCIATES
The Company is a joint venture company formed by ONGC Ltd. in association with The Energy and Resources Institute, New Delhi.
5. CONTINGENT LIABILITIES
Outstanding Bank Guarantees- Rs. 5,10,000 (Previous Tear-Rs. Nil)
6. EXPENDITURE INCURRED IN FOREIGN CURRENCY
Foreign Travel- Rs.47, 180 (Previous Year-Rs. Nil)
ONGC Teri Biotech Limited
7. The preliminary / preoperative expenses shall be written off over a period of five years.
8. Previous period figures have been regrouped / rearranged,
wherever required, to make them comparable with the current year.
9. Schedule ‘A’ to Schedule ‘E’ forms integral part of accounts and have been duly authenticated.
Auditors Report
As per our report of even date For A.K.KHURANA & ASSOCIATES
CHARTERED ACCOUNTANTS
Sd/- Sd/- Sd/- (ASHOK KHURANA) (A. K.Hazarika) (Banwari Lal)
SOLE PRACTITIONER CHAIRMAN DIRECTOR & CEO Membership No.: 084245
Place: New Delhi
Dated: 22nd May, 2010